Hall of Fame

The lawyers at the very top of the profession, widely known and respected by peers and clients for their longstanding involvement in market-leading work.

Rod Freeman

Hall of fameCooley LLP

Rod Freeman is a partner in Cooley's London office and an international products lawyer. He is routinely ranked as a leading product litigation lawyer in the major legal directories, where he is described as “the outstanding go-to specialist for product liability matters” and “without a shadow of a doubt the most knowledgeable product liability lawyer in the European space”.  Rod works alongside the world's leading global companies to help them solve their product-related issues, protect their reputations, defend their products and build more successful businesses. With a background in high-stakes product liability litigation and more than 20 year's devoted to international products law, Rod understands the challenges faced by international brand names in an increasingly risky global environment. He has the experience and insight to find creative and practical commercial solutions to product issues around the world. Rod leads a team that defends product liability litigation, handles product-related B2B disputes, manages and resolves product safety and regulatory compliance issues, and manages international product recalls. In short, Rod helps his clients find solutions to their issues that arise throughout the product life cycle.

John Blain

Hall of fameFreshfields Bruckhaus Deringer LLP

Rising stars

Rising stars with regular involvement in their team's key work, and recognition from peers or clients as being ones to watch.

Next Generation Partners

Junior partners with significant recognition from clients and peers in the market and key roles on multiple matters.

Sascha Grimm

Cooley LLP

Sascha Grimm is a partner in Cooley’s Commercial Litigation department in the London office.  Her experience spans civil litigation, regulatory investigations, as well as IP/brand protection matters and disputes arising out of product liability issues. She has particularly experience in working on large-scale projects for clients in crisis management matters where there is a significant threat to the fundamental enterprise or reputation of the client.

Peter Rudd-Clarke

Peter Rudd-Clarke

Osborne Clarke LLP

Peter specialises in helping businesses navigate regulatory challenges and liability risks, particularly in the life sciences, healthcare and consumer products sectors. Peter advises a range of businesses including medical device companies, software producers, service providers and manufacturers of lifestyle products. His regulatory experience includes advising on the regulation of medical devices and consumer products, as well as CE/UKCA marking, clinical trials, regulatory investigations and ongoing compliance matters. The litigation and risk management side to Peter’s practice involves defending manufacturers of complex products against liability claims, often across multiple jurisdictions.

Leading individuals

The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.

Louisa  Caswell

Louisa Caswell

Dentons

Louisa heads the Disputes division for Dentons in the UK. She is a leading commercial litigator with an outstanding record in big-ticket trials and complex cross-border disputes. Louisa is known for her expertise in corporate/M&A disputes including shareholder disputes, warranty and indemnity claims, and post-completion disputes over deferred consideration and earn-outs. She also has particular experience in disputes and termination issues relating to supply contracts involving products and components, logistics and IT projects. In her product litigation practice, Louisa acts for product manufacturers on product liability claims, product safety and compliance issues, and product recalls relating to food and drink, consumer goods, pharmaceuticals and technology, amongst others. Louisa defended GlaxoSmithKline in a landmark product liability group action relating to its antidepressant Seroxat and was involved in all stages of this long-running litigation.